Economics and Policy in Bariatric Surgery
- 49 Downloads
Purpose of Review
The purpose of this review is to provide current synthesis of the evidence on the cost-effectiveness of bariatric surgery for persons with diabetes.
Virtually, every study that has evaluated the cost-effectiveness of bariatric surgery for persons who are obese and have type 2 diabetes has concluded that surgery is cost-effective. A few studies outside the USA found that surgery is cost-saving. Currently, most but not all US insurers cover bariatric surgery in persons with type 2 diabetes and BMI ≥ 35 kg/m2.
Bariatric surgery is a cost-effective treatment for persons with type 2 diabetes and BMI ≥ 35 kg/m2. There is interest in extending surgery to persons with diabetes and lower BMI; the cost-effectiveness of treating these individuals with bariatric surgery should be explored. Despite the potential benefits, not all obese or overweight persons with diabetes will choose surgery.
KeywordsBariatric surgery Diabetes Cost-effectiveness
Compliance with Ethical Standards
Conflicts of Interest
The author declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Oxford Living Dictionaries. Bariatric surgery: Oxford University Press; 2019. https://en.oxforddictionaries.com/definition/us/bariatric_surgery. Accessed 31 Jan 2019.
- 3.American Society for Metabolic and Bariatric Surgery. Estimate of bariatric surgery numbers, 2011–2017. 2018. https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers. Accessed 26 Jan 2019.
- 4.•• Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–77. https://doi.org/10.2337/dc16-0236 Consensus statement from diabetes, surgical, and medical organizations recommending bariatric surgery treatment algorithm for persons with diabetes and making the case for the term “metabolic surgery. CrossRefGoogle Scholar
- 6.•• O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29(1):3–14. https://doi.org/10.1007/s11695-018-3525-0 This publication is the most-complete, systematic review of long-term weight loss and health outcomes after bariatric surgery. CrossRefPubMedGoogle Scholar
- 7.Ikramuddin S, Korner J, Lee WJ, Bantle JP, Thomas AJ, Connett JE, et al. Durability of addition of roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: a randomized control trial. Diabetes Care. 2016;39(9):1510–8. https://doi.org/10.2337/dc15-2481.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.• O'Brien R, Johnson E, Haneuse S, Coleman KJ, O'Connor PJ, Fisher DP, et al. Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care: a matched cohort study. Ann Intern Med. 2018;169(5):300–10. https://doi.org/10.7326/M17-2383 In a matched cohort study of persons with diabetes, bariatric surgery had a hazard ratio of 0.40 for microvascular events. CrossRefPubMedGoogle Scholar
- 9.• Fisher DP, Johnson E, Haneuse S, Arterburn D, Coleman KJ, O'Connor PJ, et al. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. JAMA. 2018;320(15):1570–82. https://doi.org/10.1001/jama.2018.14619 Bariatric surgery in patients with type 2 diabetes and severe obesity is associated with fewer cardiovascular events. CrossRefPubMedPubMedCentralGoogle Scholar
- 14.•• Avenell A, Robertson C, Skea Z, Jacobsen E, Boyers D, Cooper D, et al. Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation. Health Technol Assess. 2018;22(68):1–246. https://doi.org/10.3310/hta22680 This publication is the most-complete systematic review of the cost-effectiveness of bariatric surgery, lifestyle intervention, and medications in persons with severe obesity. CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Anselmino M, Bammer T, Fernandez Cebrian JM, Daoud F, Romagnoli G, Torres A. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries(II). Obes Surg. 2009;19(11):1542–9. https://doi.org/10.1007/s11695-009-9946-z.CrossRefPubMedGoogle Scholar
- 23.Pollock RF, Muduma G, Valentine WJ. Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK. Diabetes Obes Metab. 2013;15(2):121–9. https://doi.org/10.1111/j.1463-1326.2012.01692.x.CrossRefPubMedGoogle Scholar
- 24.Borisenko O, Adam D, Funch-Jensen P, Ahmed AR, Zhang R, Colpan Z, et al. Bariatric surgery can lead to net cost savings to health care systems: results from a comprehensive European decision analytic model. Obes Surg. 2015;25(9):1559–68. https://doi.org/10.1007/s11695-014-1567-5.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.•• Wentworth JM, Dalziel KM, O'Brien PE, Burton P, Shaba F, Clarke PM, et al. Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S. J Diabetes Complicat. 2017;31(7):1139–44. https://doi.org/10.1016/j.jdiacomp.2017.04.009 This publication was the first cost-effectiveness analysis of bariatric surgery in overweight (BMI 25-29 kg/m 2 ) patients with type 2 diabetes. CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Gulliford MC, Charlton J, Prevost T, Booth H, Fildes A, Ashworth M, et al. Costs and outcomes of increasing access to bariatric surgery: cohort study and cost-effectiveness analysis using electronic health records. Value Health. 2017;20(1):85–92. https://doi.org/10.1016/j.jval.2016.08.734.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.• American Diabetes Association. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S81–S9. https://doi.org/10.2337/dc19-S008 This publication includes the U.S. guidelines recommending bariatric surgery for obese persons with type 2 diabetes. CrossRefGoogle Scholar